PRF1 and neoplasm: CD4+ T cells mainly mediate anti-tumour immunity by facilitating CD8+ CTL and antibody responses, by expressing key molecules that are associated with cytolytic granules such as granzymes or perforin or via direct cytotoxicity to tumour cells [52, 53].